122 related articles for article (PubMed ID: 28606382)
1. A phase I randomized postcoital testing and safety study of the Caya diaphragm used with 3% Nonoxynol-9 gel, ContraGel or no gel.
Mauck CK; Brache V; Kimble T; Thurman A; Cochon L; Littlefield S; Linton K; Doncel GF; Schwartz JL
Contraception; 2017 Aug; 96(2):124-130. PubMed ID: 28606382
[TBL] [Abstract][Full Text] [Related]
2. A phase I comparative study of three contraceptive vaginal films containing nonoxynol-9. Postcoital testing and colposcopy.
Mauck CK; Baker JM; Barr SP; Johanson WM; Archer DF
Contraception; 1997 Aug; 56(2):97-102. PubMed ID: 9315418
[TBL] [Abstract][Full Text] [Related]
3. A phase I study of Femcap used with and without spermicide. Postcoital testing.
Mauck CK; Baker JM; Barr SP; Johanson W; Archer DF
Contraception; 1997 Aug; 56(2):111-5. PubMed ID: 9315420
[TBL] [Abstract][Full Text] [Related]
4. SILCS diaphragm: postcoital testing of a new single-size contraceptive device.
Schwartz JL; Ballagh SA; Creinin MD; Rountree RW; Kilbourne-Brook M; Mauck CK; Callahan MM
Contraception; 2008 Sep; 78(3):237-44. PubMed ID: 18692615
[TBL] [Abstract][Full Text] [Related]
5. A phase I comparative study of contraceptive vaginal films containing benzalkonium chloride and nonoxynol-9. Postcoital testing and colposcopy.
Mauck CK; Baker JM; Barr SP; Abercrombie TJ; Archer DF
Contraception; 1997 Aug; 56(2):89-96. PubMed ID: 9315417
[TBL] [Abstract][Full Text] [Related]
6. Lea's Shield: a phase I postcoital study of a new contraceptive barrier device.
Archer DF; Mauck CK; Viniegra-Sibal A; Anderson FD
Contraception; 1995 Sep; 52(3):167-73. PubMed ID: 7587188
[TBL] [Abstract][Full Text] [Related]
7. A phase I randomized safety study of a single-size silicone rubber diaphragm used with or without a lactic-acid-containing diaphragm gel.
Thurman A; Cunningham T; Fichorova R; Herold BC; Hillier SL; Chandra N; Doncel GF
Contraception; 2019 Dec; 100(6):430-437. PubMed ID: 31442441
[TBL] [Abstract][Full Text] [Related]
8. Successful postcoital testing of Ovaprene: An investigational non-hormonal monthly vaginal contraceptive.
Mauck C; Thurman A; Jensen JT; Schreiber CA; Baker J; Hou MY; Chavoustie S; Dart C; Wu H; Zack N; Hatheway J; Friend D
Contraception; 2024 Apr; 132():110373. PubMed ID: 38232942
[TBL] [Abstract][Full Text] [Related]
9. Postcoital testing after the use of a bio-adhesive acid buffering gel (ACIDFORM) and a 2% nonoxynol-9 product.
Amaral E; Perdigão A; Souza MH; Mauck C; Waller D; Zaneveld L; Faúndes A
Contraception; 2004 Dec; 70(6):492-7. PubMed ID: 15541412
[TBL] [Abstract][Full Text] [Related]
10. ZB-06, a vaginal film containing an engineered human contraceptive antibody (HC4-N), demonstrates safety and efficacy in a phase 1 postcoital test and safety study.
Thurman AR; Moench TR; Hoke M; Politch JA; Cabral H; Mausser E; Nador E; Morton J; Hamorsky K; Swope K; Bratcher B; Anderson DJ; Whaley KJ
Am J Obstet Gynecol; 2023 Jun; 228(6):716.e1-716.e12. PubMed ID: 36870409
[TBL] [Abstract][Full Text] [Related]
11. Contraceptive efficacy, safety, fit, and acceptability of a single-size diaphragm developed with end-user input.
Schwartz JL; Weiner DH; Lai JJ; Frezieres RG; Creinin MD; Archer DF; Bradley L; Barnhart KT; Poindexter A; Kilbourne-Brook M; Callahan MM; Mauck CK
Obstet Gynecol; 2015 Apr; 125(4):895-903. PubMed ID: 25751199
[TBL] [Abstract][Full Text] [Related]
12. Contraceptive efficacy of a novel spermicidal microbicide used with a diaphragm: a randomized controlled trial.
Barnhart KT; Rosenberg MJ; MacKay HT; Blithe DL; Higgins J; Walsh T; Wan L; Thomas M; Creinin MD; Westhoff C; Schlaff W; Archer DF; Ayers C; Kaunitz A; Das S; Moench TR
Obstet Gynecol; 2007 Sep; 110(3):577-86. PubMed ID: 17766603
[TBL] [Abstract][Full Text] [Related]
13. Study of the intravaginal insert (IVI): acceptability, side effects, and post-coital spermicidal activity.
Ahmad M; Asch RH
Acta Eur Fertil; 1984; 15(5):369-76. PubMed ID: 6099026
[TBL] [Abstract][Full Text] [Related]
14. Vaginal safety after use of a bioadhesive, acid-buffering, microbicidal contraceptive gel (ACIDFORM) and a 2% nonoxynol-9 product.
Amaral E; Perdigao A; Souza MH; Mauck C; Waller D; Zaneveld L; Faundes A
Contraception; 2006 May; 73(5):542-7. PubMed ID: 16627043
[TBL] [Abstract][Full Text] [Related]
15. Compatibility between the spermicide nonoxynol 9 and mid-cycle human cervical mucus.
Chantler E; Hemsworth M; Roach VP; Bruce JM
Contraception; 1992 Sep; 46(3):289-95. PubMed ID: 1333387
[TBL] [Abstract][Full Text] [Related]
16. A phase I comparative postcoital testing study of three concentrations of C31G.
Mauck CK; Creinin MD; Barnhart KT; Ballagh SA; Archer DF; Callahan MM; Schmitz SW; Bax R
Contraception; 2004 Sep; 70(3):227-31. PubMed ID: 15325892
[TBL] [Abstract][Full Text] [Related]
17. The postcoital test in the development of new vaginal contraceptives†.
Mauck CK; Vincent KL
Biol Reprod; 2020 Aug; 103(2):437-444. PubMed ID: 32657328
[TBL] [Abstract][Full Text] [Related]
18. Contraceptive efficacy, acceptability, and safety of C31G and nonoxynol-9 spermicidal gels: a randomized controlled trial.
Burke AE; Barnhart K; Jensen JT; Creinin MD; Walsh TL; Wan LS; Westhoff C; Thomas M; Archer D; Wu H; Liu J; Schlaff W; Carr BR; Blithe D
Obstet Gynecol; 2010 Dec; 116(6):1265-1273. PubMed ID: 21099590
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of an optimized benzalkonium chloride gel as vaginal contraceptive: a randomized controlled trial among Chinese women.
Li W; Huang Z; Wu Y; Wang H; Zhou X; Xiao Z; Ding X; Xu J
Contraception; 2013 Jun; 87(6):756-65. PubMed ID: 23089047
[TBL] [Abstract][Full Text] [Related]
20. Vaginal contraception--an update.
Edelman DA; Thompson S
Contracept Deliv Syst; 1982 Apr; 3(2):75-81. PubMed ID: 12338173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
